New Biochemical Markers and Anti-Amyloid Antibody Treatments of Alzheimer’s Disease
From a diagnostic standpoint, biochemical support for an Alzheimer’s disease diagnosis has become much more available. This development goes hand in hand with the recent developments in the treatment of Alzheimer’s disease with anti-amyloid antibodies and other interesting potential treatments that are underway. Henrik Zetterberg, professor at the University of Gothenburg and University College London, gives you his update in this MEDtalk.
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.